Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Relay Therapeutics Inc (NQ: RLAY ) 6.440 -0.120 (-1.83%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 599,033 Open 6.590 Bid (Size) 6.050 (1) Ask (Size) 7.080 (1) Prev. Close 6.560 Today's Range 6.325 - 6.600 52wk Range 5.700 - 12.14 Shares Outstanding 121,613,181 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Expert Ratings For Relay Therapeutics August 07, 2024 Via Benzinga RLAY Stock Earnings: Relay Therapeutics Beats EPS for Q2 2024 August 06, 2024 RLAY stock results show that Relay Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Performance YTD -45.68% -45.68% 1 Month -22.13% -22.13% 3 Month -5.22% -5.22% 6 Month -34.88% -34.88% 1 Year -39.36% -39.36% More News Read More Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights August 06, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire Relay Therapeutics to Announce Second Quarter 2024 Financial Results and Corporate Highlights on August 6, 2024 July 30, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire Expert Ratings For Relay Therapeutics July 17, 2024 Via Benzinga Expert Ratings For Relay Therapeutics June 07, 2024 Via Benzinga Key Takeaways From Relay Therapeutics Analyst Ratings May 10, 2024 Via Benzinga AI-Focused Drug Discovery Stocks Portfolio Up 7% Last Week; Up 19% MTD July 30, 2024 Via Talk Markets These 7 AI Stocks Were Major Movers On Monday/Tuesday - Here's Why July 24, 2024 Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence AI-Powered Drug Discovery Stocks Portfolio Up 14% MTD; Still Down 30% YTD July 18, 2024 Via Talk Markets Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD July 14, 2024 Via Talk Markets Clinical-Stage BioTech Drug Stocks Declined 13% In June July 01, 2024 Via Talk Markets Largest Clinical-Stage BioTech Drug Stocks Declined 6% June 22, 2024 Via Talk Markets AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th June 17, 2024 Via Talk Markets AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week June 10, 2024 Via Talk Markets Relay Therapeutics Discloses Three New Programs at New Program & Platform Event June 06, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608 June 05, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire Largest Clinical-Stage BioTech Drug Stocks Declined Slightly Last Week May 27, 2024 Via Talk Markets Relay Therapeutics to Participate in Upcoming Investor Conferences May 21, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire Relay Therapeutics to Host New Program and Platform Event on June 6, 2024 May 13, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire 5 Of 7 AI Categories Rose, Slightly,Over Past Week May 11, 2024 Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence The 7 AI Categories Declined, On Average, The First Week Of May May 05, 2024 Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence Clinical-Stage BioTech Drug Stocks Portfolio Jumped 7% In First Week Of May May 05, 2024 Via Talk Markets RLAY Stock Earnings: Relay Therapeutics Beats EPS, Beats Revenue for Q1 2024 May 02, 2024 Via InvestorPlace Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights May 02, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
